Birchview Capital, LP Kiniksa Pharmaceuticals, Ltd. Transaction History
Birchview Capital, LP
- $108 Million
- Q3 2024
A detailed history of Birchview Capital, LP transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Birchview Capital, LP holds 30,000 shares of KNSA stock, worth $598,200. This represents 0.69% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,000
-0.0%
Holding current value
$598,200
Previous $560,000
33.75%
% of portfolio
0.69%
Previous 0.56%
Shares
2 transactions
Others Institutions Holding KNSA
# of Institutions
8Shares Held
1.95MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$30.3 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$4.04 Million2.82% of portfolio
-
Harbor Capital Advisors, Inc.97.5KShares$1.95 Million0.11% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$787,3500.0% of portfolio
-
Credit Suisse Ag Zurich, V828.9KShares$576,7440.0% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $687M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...